A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma

ABSTRACT: BACKGROUND: The role of chemotherapy in high-risk soft tissue sarcoma is controversial. Though many patients undergo initial curative resection, distant metastasis is a frequent event, resulting in 5-year overall survival rates of only 50-60%. Neo-adjuvant and adjuvant chemotherapy (CTX) h...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitt, Thomas, Lehner, Burkhard, Kasper, Bernd, Bischof, Marc, Roeder, Falk, Dietrich, Sascha, Dimitrakopoulou-Strauss, Antonia, Strauss, Ludwig G, Mechtersheimer, Gunhild, Wuchter, Patrick, Ho, Anthony D, Egerer, Gerlinde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248452/
https://www.ncbi.nlm.nih.gov/pubmed/22152120
http://dx.doi.org/10.1186/1471-2407-11-510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248452/
https://www.ncbi.nlm.nih.gov/pubmed/22152120
http://dx.doi.org/10.1186/1471-2407-11-510

Ejemplares similares